Nasal sprays reduce cold duration in at-risk patients by 25%: Study
HQ Team July 18, 2024: A United Kingdom study found that Over-the-counter (OTC) nasal sprays can reduce the symptoms and duration of respiratory.
Bharti Rana Jayshankar – Founder
She brings in more than 30 years of experience in content building, architecture, writing, editing and storytelling. Ms Jayshankar has worked in the Economic Times daily, IBT Times, Investopedia and more than a dozen content firms as a content strategist and planner.
Jay Shankar – Co-founder
He has almost three decades of experience in journalism. He has worked with national dailies such as ET, Indian Express, The Pioneer, The Hindu, Agence France Presse and Bloomberg.
HQ Team July 18, 2024: A United Kingdom study found that Over-the-counter (OTC) nasal sprays can reduce the symptoms and duration of respiratory.